Ocular adverse effects associated with cyclooxygenase-2 inhibitors.

1. Zimmerman LE, Garron LK. Melanocytoma of the optic disc. Int Ophthalmol Clin. 1962;2: 431-440. 2. Joffe L, Shields JA, Osher RH, Gass JD. Clinical and follow-up studies of melanocytomas of the optic disc. Ophthalmology. 1979;86:10671083. 3. Spencer WH. XXXIV Edward Jackson Memorial Lecture: drusen of the optic disc and aberrant axoplasmic transport. Ophthalmology. 1978;85:21-38. 4. Osher RH, Shields JA, Layman PR. Pupillary and visual field evaluation in patients with melanocytoma of the optic disc. Arch Ophthalmol. 1979;97:1096-1099. 5. Shields JA, Shields CL, Eagle RC Jr, Singh AD, Berrocal MH, Berrocal JA. Central retinal vascular obstruction secondary to melanocytoma of the optic disc. Arch Ophthalmol. 2001;119: 129-133. 6. Croxatto JO, Ebner R, Crovetto L, Morales AG. Angle closure glaucoma as initial manifestation of melanocytoma of the optic disc. Ophthalmology. 1983;90:830-834. 7. Zimmerman LE. Melanocytes, melanocytic nevi, and melanocytomas. Invest Ophthalmol. 1965; 34:11-41. 8. Takahashi T, Isayama Y, Okuzawa I. Unusual case of melanocytoma in optic disk. Jpn J Ophthalmol. 1984;28:171-175. 9. Lessell S, Cohen MM. Phosphenes induced by sound. Neurology. 1979;29:1524-1526. 10. Page NG, Bolger JP, Sanders MD. Auditory evoked phosphenes in optic nerve disease. J Neurol Neurosurg Psychiatry. 1982;45:7-12.